nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2A—phrenic nerve—thymus cancer	0.0634	0.284	CbGeAlD
Duloxetine—Abdominal tenderness—Octreotide—thymus cancer	0.0377	0.0486	CcSEcCtD
Duloxetine—Hepatic steatosis—Octreotide—thymus cancer	0.0316	0.0406	CcSEcCtD
Duloxetine—Diabetic—Octreotide—thymus cancer	0.0285	0.0367	CcSEcCtD
Duloxetine—HTR2A—pulmonary artery—thymus cancer	0.023	0.103	CbGeAlD
Duloxetine—HTR2A—vein—thymus cancer	0.021	0.0939	CbGeAlD
Duloxetine—Loss of libido—Octreotide—thymus cancer	0.0206	0.0266	CcSEcCtD
Duloxetine—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0181	0.0233	CcSEcCtD
Duloxetine—NPY1R—hematopoietic system—thymus cancer	0.0174	0.0778	CbGeAlD
Duloxetine—Loose stools—Octreotide—thymus cancer	0.0172	0.0222	CcSEcCtD
Duloxetine—Hypothyroidism—Octreotide—thymus cancer	0.0148	0.0191	CcSEcCtD
Duloxetine—Galactorrhoea—Octreotide—thymus cancer	0.0147	0.0189	CcSEcCtD
Duloxetine—Menstrual disorder—Octreotide—thymus cancer	0.014	0.018	CcSEcCtD
Duloxetine—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0138	0.0178	CcSEcCtD
Duloxetine—NPY1R—pituitary gland—thymus cancer	0.0129	0.0577	CbGeAlD
Duloxetine—Endocrine disorder—Octreotide—thymus cancer	0.0115	0.0148	CcSEcCtD
Duloxetine—NPY1R—thyroid gland—thymus cancer	0.0111	0.0497	CbGeAlD
Duloxetine—Contusion—Octreotide—thymus cancer	0.0109	0.0141	CcSEcCtD
Duloxetine—Oropharyngeal pain—Octreotide—thymus cancer	0.0105	0.0135	CcSEcCtD
Duloxetine—NPY1R—lung—thymus cancer	0.0101	0.0452	CbGeAlD
Duloxetine—Muscle twitching—Octreotide—thymus cancer	0.0097	0.0125	CcSEcCtD
Duloxetine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00953	0.0123	CcSEcCtD
Duloxetine—Eructation—Octreotide—thymus cancer	0.00936	0.0121	CcSEcCtD
Duloxetine—Influenza like illness—Octreotide—thymus cancer	0.00925	0.0119	CcSEcCtD
Duloxetine—Urine output increased—Octreotide—thymus cancer	0.00862	0.0111	CcSEcCtD
Duloxetine—Phlebitis—Octreotide—thymus cancer	0.00803	0.0103	CcSEcCtD
Duloxetine—Sleep disorder—Octreotide—thymus cancer	0.00799	0.0103	CcSEcCtD
Duloxetine—Diabetes mellitus—Octreotide—thymus cancer	0.00795	0.0102	CcSEcCtD
Duloxetine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00795	0.0102	CcSEcCtD
Duloxetine—Polyuria—Octreotide—thymus cancer	0.00788	0.0101	CcSEcCtD
Duloxetine—Gastroenteritis—Octreotide—thymus cancer	0.0078	0.01	CcSEcCtD
Duloxetine—Cardiac failure congestive—Octreotide—thymus cancer	0.00763	0.00982	CcSEcCtD
Duloxetine—Hot flush—Octreotide—thymus cancer	0.00739	0.00952	CcSEcCtD
Duloxetine—Menopausal symptoms—Octreotide—thymus cancer	0.00733	0.00944	CcSEcCtD
Duloxetine—SLC6A3—hematopoietic system—thymus cancer	0.0073	0.0327	CbGeAlD
Duloxetine—Visual disturbance—Octreotide—thymus cancer	0.0073	0.00939	CcSEcCtD
Duloxetine—Hypoglycaemia—Octreotide—thymus cancer	0.00709	0.00912	CcSEcCtD
Duloxetine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00692	0.0089	CcSEcCtD
Duloxetine—Pain in extremity—Octreotide—thymus cancer	0.00692	0.0089	CcSEcCtD
Duloxetine—Osteoarthritis—Octreotide—thymus cancer	0.00692	0.0089	CcSEcCtD
Duloxetine—NPY1R—lymph node—thymus cancer	0.00689	0.0309	CbGeAlD
Duloxetine—SLC6A4—hematopoietic system—thymus cancer	0.00669	0.03	CbGeAlD
Duloxetine—Irritability—Octreotide—thymus cancer	0.0066	0.0085	CcSEcCtD
Duloxetine—Dehydration—Octreotide—thymus cancer	0.00643	0.00828	CcSEcCtD
Duloxetine—Abdominal pain upper—Octreotide—thymus cancer	0.00632	0.00813	CcSEcCtD
Duloxetine—Cramp muscle—Octreotide—thymus cancer	0.00623	0.00802	CcSEcCtD
Duloxetine—Nasopharyngitis—Octreotide—thymus cancer	0.00619	0.00796	CcSEcCtD
Duloxetine—Gastritis—Octreotide—thymus cancer	0.00612	0.00788	CcSEcCtD
Duloxetine—Muscular weakness—Octreotide—thymus cancer	0.0061	0.00785	CcSEcCtD
Duloxetine—Influenza—Octreotide—thymus cancer	0.00598	0.00769	CcSEcCtD
Duloxetine—Pancreatitis—Octreotide—thymus cancer	0.00586	0.00754	CcSEcCtD
Duloxetine—Sweating increased—Octreotide—thymus cancer	0.00582	0.0075	CcSEcCtD
Duloxetine—Abdominal discomfort—Octreotide—thymus cancer	0.00573	0.00738	CcSEcCtD
Duloxetine—Dysuria—Octreotide—thymus cancer	0.00559	0.0072	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00556	0.00715	CcSEcCtD
Duloxetine—Pollakiuria—Octreotide—thymus cancer	0.00552	0.00711	CcSEcCtD
Duloxetine—Weight increased—Octreotide—thymus cancer	0.00544	0.007	CcSEcCtD
Duloxetine—Weight decreased—Octreotide—thymus cancer	0.00541	0.00696	CcSEcCtD
Duloxetine—Hyperglycaemia—Octreotide—thymus cancer	0.00539	0.00694	CcSEcCtD
Duloxetine—Jaundice—Octreotide—thymus cancer	0.0052	0.00669	CcSEcCtD
Duloxetine—Conjunctivitis—Octreotide—thymus cancer	0.00518	0.00667	CcSEcCtD
Duloxetine—Urinary tract infection—Octreotide—thymus cancer	0.00518	0.00667	CcSEcCtD
Duloxetine—Hepatobiliary disease—Octreotide—thymus cancer	0.00504	0.00649	CcSEcCtD
Duloxetine—Epistaxis—Octreotide—thymus cancer	0.00503	0.00647	CcSEcCtD
Duloxetine—Hepatitis—Octreotide—thymus cancer	0.00479	0.00616	CcSEcCtD
Duloxetine—Hypoaesthesia—Octreotide—thymus cancer	0.00476	0.00613	CcSEcCtD
Duloxetine—HTR2A—neck—thymus cancer	0.00476	0.0213	CbGeAlD
Duloxetine—Pharyngitis—Octreotide—thymus cancer	0.00475	0.00611	CcSEcCtD
Duloxetine—Oedema peripheral—Octreotide—thymus cancer	0.00471	0.00607	CcSEcCtD
Duloxetine—Visual impairment—Octreotide—thymus cancer	0.00461	0.00594	CcSEcCtD
Duloxetine—CYP1A2—hematopoietic system—thymus cancer	0.00453	0.0203	CbGeAlD
Duloxetine—Tinnitus—Octreotide—thymus cancer	0.00446	0.00574	CcSEcCtD
Duloxetine—Cardiac disorder—Octreotide—thymus cancer	0.00444	0.00572	CcSEcCtD
Duloxetine—Flushing—Octreotide—thymus cancer	0.00444	0.00572	CcSEcCtD
Duloxetine—Immune system disorder—Octreotide—thymus cancer	0.00432	0.00556	CcSEcCtD
Duloxetine—Arrhythmia—Octreotide—thymus cancer	0.00427	0.0055	CcSEcCtD
Duloxetine—SLC6A3—lung—thymus cancer	0.00424	0.019	CbGeAlD
Duloxetine—Alopecia—Octreotide—thymus cancer	0.00423	0.00544	CcSEcCtD
Duloxetine—Mental disorder—Octreotide—thymus cancer	0.00419	0.0054	CcSEcCtD
Duloxetine—Malnutrition—Octreotide—thymus cancer	0.00417	0.00536	CcSEcCtD
Duloxetine—Erythema—Octreotide—thymus cancer	0.00417	0.00536	CcSEcCtD
Duloxetine—Flatulence—Octreotide—thymus cancer	0.0041	0.00528	CcSEcCtD
Duloxetine—Tension—Octreotide—thymus cancer	0.00409	0.00526	CcSEcCtD
Duloxetine—Nervousness—Octreotide—thymus cancer	0.00405	0.00521	CcSEcCtD
Duloxetine—Back pain—Octreotide—thymus cancer	0.00403	0.00519	CcSEcCtD
Duloxetine—Muscle spasms—Octreotide—thymus cancer	0.004	0.00515	CcSEcCtD
Duloxetine—Vision blurred—Octreotide—thymus cancer	0.00393	0.00505	CcSEcCtD
Duloxetine—Tremor—Octreotide—thymus cancer	0.0039	0.00502	CcSEcCtD
Duloxetine—SLC6A4—lung—thymus cancer	0.00389	0.0174	CbGeAlD
Duloxetine—Ill-defined disorder—Octreotide—thymus cancer	0.00386	0.00497	CcSEcCtD
Duloxetine—Anaemia—Octreotide—thymus cancer	0.00385	0.00496	CcSEcCtD
Duloxetine—Agitation—Octreotide—thymus cancer	0.00383	0.00493	CcSEcCtD
Duloxetine—Malaise—Octreotide—thymus cancer	0.00376	0.00484	CcSEcCtD
Duloxetine—Vertigo—Octreotide—thymus cancer	0.00374	0.00482	CcSEcCtD
Duloxetine—Syncope—Octreotide—thymus cancer	0.00374	0.00481	CcSEcCtD
Duloxetine—Palpitations—Octreotide—thymus cancer	0.00368	0.00474	CcSEcCtD
Duloxetine—Loss of consciousness—Octreotide—thymus cancer	0.00366	0.00471	CcSEcCtD
Duloxetine—Cough—Octreotide—thymus cancer	0.00363	0.00468	CcSEcCtD
Duloxetine—Convulsion—Octreotide—thymus cancer	0.00361	0.00465	CcSEcCtD
Duloxetine—Hypertension—Octreotide—thymus cancer	0.0036	0.00463	CcSEcCtD
Duloxetine—Arthralgia—Octreotide—thymus cancer	0.00355	0.00456	CcSEcCtD
Duloxetine—Chest pain—Octreotide—thymus cancer	0.00355	0.00456	CcSEcCtD
Duloxetine—Myalgia—Octreotide—thymus cancer	0.00355	0.00456	CcSEcCtD
Duloxetine—HTR2A—hematopoietic system—thymus cancer	0.00354	0.0159	CbGeAlD
Duloxetine—Anxiety—Octreotide—thymus cancer	0.00353	0.00455	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00352	0.00453	CcSEcCtD
Duloxetine—Discomfort—Octreotide—thymus cancer	0.0035	0.00451	CcSEcCtD
Duloxetine—Dry mouth—Octreotide—thymus cancer	0.00347	0.00446	CcSEcCtD
Duloxetine—SLC6A2—lung—thymus cancer	0.00342	0.0153	CbGeAlD
Duloxetine—Anaphylactic shock—Octreotide—thymus cancer	0.0034	0.00438	CcSEcCtD
Duloxetine—Oedema—Octreotide—thymus cancer	0.0034	0.00438	CcSEcCtD
Duloxetine—Infection—Octreotide—thymus cancer	0.00338	0.00435	CcSEcCtD
Duloxetine—Shock—Octreotide—thymus cancer	0.00334	0.00431	CcSEcCtD
Duloxetine—Nervous system disorder—Octreotide—thymus cancer	0.00333	0.00429	CcSEcCtD
Duloxetine—Thrombocytopenia—Octreotide—thymus cancer	0.00333	0.00428	CcSEcCtD
Duloxetine—Tachycardia—Octreotide—thymus cancer	0.00332	0.00427	CcSEcCtD
Duloxetine—Skin disorder—Octreotide—thymus cancer	0.0033	0.00425	CcSEcCtD
Duloxetine—Hyperhidrosis—Octreotide—thymus cancer	0.00329	0.00423	CcSEcCtD
Duloxetine—Anorexia—Octreotide—thymus cancer	0.00324	0.00417	CcSEcCtD
Duloxetine—HTR2A—epithelium—thymus cancer	0.00324	0.0145	CbGeAlD
Duloxetine—CYP2D6—hematopoietic system—thymus cancer	0.00323	0.0145	CbGeAlD
Duloxetine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0031	0.00399	CcSEcCtD
Duloxetine—Insomnia—Octreotide—thymus cancer	0.00307	0.00396	CcSEcCtD
Duloxetine—Paraesthesia—Octreotide—thymus cancer	0.00305	0.00393	CcSEcCtD
Duloxetine—Somnolence—Octreotide—thymus cancer	0.00302	0.00389	CcSEcCtD
Duloxetine—Dyspepsia—Octreotide—thymus cancer	0.00299	0.00385	CcSEcCtD
Duloxetine—Decreased appetite—Octreotide—thymus cancer	0.00296	0.0038	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00293	0.00378	CcSEcCtD
Duloxetine—Fatigue—Octreotide—thymus cancer	0.00293	0.00377	CcSEcCtD
Duloxetine—Pain—Octreotide—thymus cancer	0.00291	0.00374	CcSEcCtD
Duloxetine—Constipation—Octreotide—thymus cancer	0.00291	0.00374	CcSEcCtD
Duloxetine—CYP1A2—thyroid gland—thymus cancer	0.0029	0.013	CbGeAlD
Duloxetine—Feeling abnormal—Octreotide—thymus cancer	0.0028	0.00361	CcSEcCtD
Duloxetine—Gastrointestinal pain—Octreotide—thymus cancer	0.00278	0.00358	CcSEcCtD
Duloxetine—Urticaria—Octreotide—thymus cancer	0.0027	0.00348	CcSEcCtD
Duloxetine—Body temperature increased—Octreotide—thymus cancer	0.00269	0.00346	CcSEcCtD
Duloxetine—Abdominal pain—Octreotide—thymus cancer	0.00269	0.00346	CcSEcCtD
Duloxetine—CYP1A2—lung—thymus cancer	0.00263	0.0118	CbGeAlD
Duloxetine—HTR2A—pituitary gland—thymus cancer	0.00263	0.0118	CbGeAlD
Duloxetine—Hypersensitivity—Octreotide—thymus cancer	0.0025	0.00322	CcSEcCtD
Duloxetine—Asthenia—Octreotide—thymus cancer	0.00244	0.00314	CcSEcCtD
Duloxetine—Pruritus—Octreotide—thymus cancer	0.00241	0.0031	CcSEcCtD
Duloxetine—SLC6A2—lymph node—thymus cancer	0.00234	0.0105	CbGeAlD
Duloxetine—Diarrhoea—Octreotide—thymus cancer	0.00233	0.00299	CcSEcCtD
Duloxetine—Dizziness—Octreotide—thymus cancer	0.00225	0.00289	CcSEcCtD
Duloxetine—Vomiting—Octreotide—thymus cancer	0.00216	0.00278	CcSEcCtD
Duloxetine—Rash—Octreotide—thymus cancer	0.00214	0.00276	CcSEcCtD
Duloxetine—Dermatitis—Octreotide—thymus cancer	0.00214	0.00276	CcSEcCtD
Duloxetine—Headache—Octreotide—thymus cancer	0.00213	0.00274	CcSEcCtD
Duloxetine—HTR2A—lung—thymus cancer	0.00206	0.00922	CbGeAlD
Duloxetine—Nausea—Octreotide—thymus cancer	0.00202	0.0026	CcSEcCtD
